ERICA JEFFERIES: Open Payments
NPI 1699262014 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 10 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $479 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Axsome Therapeutics, Inc. | 1 | $85 |
| PFIZER INC. | 1 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: INGREZZA, Auvelity, ZAVZPRET, FANAPT, CAPLYTA, CAMZYOS, UBRELVY, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
